Company news

LifeMD, Inc. news in 2026

LifeMD, Inc.'s news releases, calls and decks from 2026, newest first.

View company

LifeMD to Report Third Quarter 2026 Financial Results on November 9

October 20, 2026

UPDATE - LifeMD Reports Second Quarter 2026 Results

August 5, 2026

LifeMD Reports Second Quarter 2026 Results

August 5, 2026

LifeMD to Report Second Quarter 2026 Financial Results on August 5

July 24, 2026

LifeMD Announces Exclusive Collaboration to Launch Direct-to-Patient Self-Pay Program for XYOSTED® (testosterone enanthate) Injection

June 21, 2026

LifeMD Appoints Umesh Sripad as Chief Technology Officer

June 1, 2026

LifeMD to Participate in Upcoming Investor Conferences

May 15, 2026

LifeMD Reports First Quarter 2026 Results

May 6, 2026

LifeMD to Report First Quarter 2026 Financial Results on May 6

April 27, 2026

LifeMD(R) Now Offering Eli Lilly and Company's Foundayo (orforglipron), a New GLP-1 Pill for Weight Management

April 13, 2026

LifeMD® Now Offering Eli Lilly and Company’s Foundayo™ (orforglipron), a New GLP-1 Pill for Weight Management

April 10, 2026

LifeMD Offers Novo Nordisk's Industry-First Wegovy Telehealth Subscription Program

April 1, 2026

LifeMD Offers Novo Nordisk's Industry-First Wegovy® Telehealth Subscription Program

March 31, 2026

LifeMD Appoints Veteran Healthcare Finance Executive as Chief Financial Officer and Expands Leadership Team

March 15, 2026

LifeMD Reports Fourth Quarter and Full Year 2025 Results

March 8, 2026

LifeMD to Participate in Two Investor Conferences During March

March 3, 2026

LifeMD to Report Fourth Quarter 2025 Financial Results on March 9

February 23, 2026

LifeMD Announces Closing of $50 Million Revolving Credit Facility with Citizens Bank, N.A.

January 6, 2026

LifeMD Expands Collaboration with Novo Nordisk as Recognized Telehealth Partner Offering Newly Approved Wegovy® Pill

January 5, 2026

Calls in 2026

Decks in 2026